New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CAMP4 Therapeutics Corporation
CAMP
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

97M

Biotechnology

Next Earning date - 20 Feb 2025

97M

Biotechnology

Next Earning date - 20 Feb 2025

4.82USD

Shape-0.36 ( -6.95%)
moonAfter-hours 4.83$arrow-right-up0.01 (0.10%)
Market Closed (as of Feb 06, 21:00 EDT)
favorite-chart

Relative Strenght

12
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

61%

Quote Panel

Shape
Updated February 6, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

CAMP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$229M

Shape327%

2024-Revenue

$2.10

Shape7%

2024-EPS

$12M

Shape809%

2024-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

William Blair

initialise

Previous: Not converted

2024-11-05

Now: Outperform

Leerink Partners

initialise

Previous: Not converted

2024-11-05

Now: Outperform

Piper Sandler

initialise

Previous: Not converted

2024-11-05

Now: Overweight

Raymond James

upgrade

Previous: Not converted

2023-06-26

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.23
vs 3.22

Q2.22

arrow
arrow

N/A

-2.30
vs 1.84

Q3.22

arrow
arrow

N/A

-0.46
vs 1.84

Q4.22

arrow
arrow

N/A

-0.06
vs -1.84

Q1.23

arrow
arrow

+700%

1.38
vs -0.23

Q2.23

arrow
arrow

N/A

-0.23
vs -2.30

Q3.23

arrow
arrow

N/A

-0.01
vs -0.46

Q4.23

arrow
arrow

N/A

-3.91
vs -0.06

Q1.24

arrow
arrow

N/A

-2.04
vs 1.38

Q2.24

arrow
arrow

N/A

-0.92
vs -0.23

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-17%

68.4M  vs 81.9M

Q2.22

arrow
arrow

-19%

64.7M  vs 79.7M

Q3.22

arrow
arrow

-8%

72.8M  vs 79M

Q4.22

arrow
arrow

+15%

78.9M  vs 68.8M

Q1.23

arrow
arrow

+15%

78.5M  vs 68.4M

Q2.23

arrow
arrow

+10%

70.9M  vs 64.7M

Q3.23

arrow
arrow

-15%

61.7M  vs 72.8M

Q4.23

arrow
arrow

-32%

53.6M  vs 78.9M

Q1.24

arrow
arrow

-35%

51.3M  vs 78.5M

Q2.24

arrow
arrow

-24%

54M  vs 70.9M

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-12%

-0.12
vs -0.14

Q2.22

arrow
arrow

-43%

-0.43
vs -0.12

Q3.22

arrow
arrow

-34%

-0.34
vs -0.43

Q4.22

arrow
arrow

-25%

-0.25
vs -0.34

Q1.23

arrow
arrow

-57%

-0.57
vs -0.25

Q2.23

arrow
arrow

-32%

-0.32
vs -0.57

Q3.23

arrow
arrow

-40%

-0.40
vs -0.32

Q4.23

arrow
arrow

+115%

1.15
vs -0.40

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

101

101
vs 101

NA

Q4.22

arrow
arrow

98

98
vs 101

-3%

Q1.23

arrow
arrow

88

88
vs 98

-10%

Q2.23

arrow
arrow

71

71
vs 88

-19%

Q3.23

arrow
arrow

58

58
vs 71

-18%

Q4.23

arrow
arrow

49

49
vs 58

-16%

Q1.24

arrow
arrow

1

1
vs 49

-98%

Q2.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News